Ginkgo is a high-growth, well-capitalized public biotech company in Boston that is redesigning the living world to solve some of the globe’s growing challenges in health, energy, food, materials, and more. Our mission to “make biology easier to engineer” is poised to disrupt multiple industries by leveraging our innovative data, automation, and scale in biological engineering. Ginkgo has built a platform for "cell engineering" to use AI/ML tools for DNA design, long DNA synthesis and assembly, next-gen sequencing, automated culturing, assay development, high-throughput high-content screening to advance pre-clinical research and development as well as manufacturing process optimization across therapeutic modalities.

Ginkgo is a partner driven company with over 100 programs running on the platform. We are seeking to enable drug-developers but have no designs to develop therapeutics ourselves. Within Ginkgo, the Mammalian Engineering team consists of a set of scientists and engineers with subject matter expertise across cell therapy, gene therapy, RNA therapeutics, and biologics. This team is responsible for translating challenges our partners have into actionable R&D programs that leverage the broader Ginkgo platform’s resources (aka the Foundry); and then manage and execute on those programs to deliver solutions on time and budget. Ginkgo has a number of public and confidential programs in gene therapy, including but not limited to improving AAV manufacturing with Biogen, AAV capsid engineering with Selecta Bio and improving strength and tissue specificity of promoters in GTx applications. We have also invested in novel promoter screening technology through acquisition of Circularis and AAV capsids through acquisition of StrideBio’s STRIVE platform for capsid discovery and engineering. As a partner-driven platform company we are not married to one modality and are generally interested in enabling any partner’s delivery strategy provided that engineering biology will help move the needle forward.

We are looking for a Senior Director, Gene Therapy to continue building and managing our portfolio of gene therapy programs. The ideal candidate will have had experiences both developing gene therapy platforms and driving preclinical and/or clinical programs with increasing leadership responsibilities throughout their career. The position requires a combination of deep technical understanding, general business acumen, project management skills, superior communication skills, and the ability to grow and lead scientific teams. This is a leadership role reporting to the VP of Mammalian Engineering.

#LI-MB1

To learn more about Ginkgo, visit www.ginkgobioworks.com/press/ or check out some curated press below:

We also feel that it’s important to point out the obvious here – there’s a serious lack of diversity in our industry, and that needs to change. Our goal is to help drive that change. Ginkgo is deeply committed to diversity, equity, and inclusion in all of its practices, especially when it comes to growing our team. Our culture promotes inclusion and embraces how rewarding it is to work with people from all walks of life.

We’re developing a powerful biological engineering platform, so we must remain mindful of the many ways our technology can – and will – impact people around the world. We care about how our platform is used, and having a diverse team to build it gives us the best chance that it’s something we’ll be proud of as it continues to grow. Therefore, it’s critical that we incorporate the diverse voices and visions of all those who play a role in the future of biology.

It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees and employment applicants.